Skip to main content
Premium Trial:

Request an Annual Quote

Bayer Schering Pharma Renews License for GeneGo's MetaCore

NEW YORK (GenomeWeb News) — Bayer Schering Pharma has renewed its licenses for GeneGo’s MetaCore software and databases, GeneGo said today.
 
St. Joseph, Mich.-based GeneGo said that Bayer Schering Pharma has agreed to another three-year license for the software, which is designed for use in target selection and validation, data mining, and for identifying biomarkers for disease states and toxicology. Bayer Schering Pharma is using the software in its oncology, cardiology, and women’s health programs, GeneGo VP of Business Development Julie Bryant said in a statement.
 
GeneGo also said it is currently developing disease-specific platforms for cancer and cardiovascular studies that “blueprint pathway maps for the disease, processes and mechanisms as well as offering public domain experimental data and disease ontologies.”
 
Financial terms of the agreement were not released.

Filed under

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.